Status:
COMPLETED
Analgesic Control Following Knee Arthroscopy
Lead Sponsor:
Orthopaedic Research and Innovation Foundation, Ireland
Conditions:
Knee
Arthroscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate the analgesic effects offered by bupivacaine and Durolane (a hyaluronic acid supplement) administered immediately following the completion of knee arthroscopy.
Detailed Description
There is increasing evidence of the toxic effects of intraarticular administration of local anaesthetic. Hyaluronic acid supplementation given at the time of knee arthroscopy has not been fully evalua...
Eligibility Criteria
Inclusion
- those undergoing knee arthroscopy for: diagnostic purposes, removal of loose bodies, articular cartilage debridement or, meniscectomy
- age over 18 years
Exclusion
- American Society of Anaesthesiologists (ASA) grade ≥3;
- arthroscopic assisted osteotomies;
- a history of two or more prior procedures on the ipsilateral knee;
- post-operative morbidities indirectly linked to the procedure (e.g. anaesthetic complications, DVT or PE);
- systemic steroid requirements;
- previous intra-articular anaesthetic or steroid injection within the last three months;
- intra-articular HA injection within the last nine months;
- intra-articular sepsis within the previous three months;
- prior history of knee arthroplasty, peri-articular fracture, ligamentous instability, inflammatory arthritis or a previous diagnosis of Complex Regional Pain Syndrome.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT01169389
Start Date
January 1 2009
End Date
June 1 2009
Last Update
July 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sports Surgery Clinic
Dublin, Ireland